|
||
 |
||
|
Treatment for primary hyperaldosteronism: - For three to four weeks, Aldactone is administered at a daily dosage of 400 mg for the long test. Aldactone may be administered in doses of 100 to 400 mg daily in preparation for surgery after the diagnosis of hyperaldosteronism has been established by more definitive testing procedures. Aldactone may be employed for long-term maintenance therapy at the lowest effective dosage determined for the individual patients who are considered unsuitable for surgery. Treatment for edema in adults: - Aldactone may be administered for an initial daily dosage of 100 mg, but may range from 25 to 200 mg daily. Aldactone should be continued for at least five days at the initial dosage level when given as the sole agent for diuresis. It may be adjusted to the optimal therapeutic or maintenance level administered in either single or divided daily doses. Aldactone dosage should remain unchanged when other diuretic therapy is added. Treatment for essential hypertension: An initial daily dosage of 50 to 100 mg of Aldactone administered in either single or divided doses is recommended. Afterward, dosage may be adjusted according to the response of the patient. Treatment for hypokalemia: - Aldactone in a dosage ranging from 25 mg to 100 mg daily is recommended. |
||
|
||
|
||
|
||
|
- CHECKOUT
- English
- German
- US Dollar
- Euro
- UK Pound
- Canadian Dollar
- Swiss Frank
- Australian Dollar
